Search
Filter Results
Displaying 61–70 of 723 for “Visions 2020”
-
The Foundation Fighting Blindness is inviting you to share your vision-loss journey through written word, audio or video as a part of our October “Share Your Vision” campaign. Help your friends, family, and even people you don’t know, see the world through your eyes—because your story is powerful and unique.
-
Jun 27, 2022
Kiora to Launch Clinical Trial in Australia for Vision-Restoring Small Molecule for RP Patients
The approach bestows light sensitivity to retinal ganglion cells for people who have lost their photoreceptors
-
Apr 1, 2022
Drug for Alcohol Abuse May Restore Vision for People with Retinal Diseases
The drug holds promise for enabling retinal-disease patients to get more vision from remaining photoreceptors
-
Vision and Eye Health Awareness Calendar
Many different blindness-related awareness campaigns occur throughout the year. Not all of them are coordinated by the Foundation Fighting Blindness; however, we do support efforts to create a greater awareness of blindness.
-
Dec 20, 2017
History Is Made: FDA Approves Spark's Vision-Restoring Gene Therapy
Known as LUXTURNA™ (voretigene neparvovec), the gene therapy restored vision in a clinical trial for people between the ages of 4 and 44 with Leber congenital amaurosis (LCA) caused by mutations in the gene RPE65.
-
Oct 8, 2015
A Leap Forward: Spark Therapeutics Seeks FDA Approval for its Vision-Restoring Gene Therapy
-
May 13, 2015
ARVO 2015 Highlight: New Research Boosts Prospects for Saving Vision with RdCVF
After years of refinement and testing in animal models, the emerging therapy is about a year and a half from moving into a clinical trial.
-
May 8, 2014
ARVO 2014: European Collaboration Developing Cross-Cutting, Vision-Saving Therapies
Simply put, they’re creating therapies that can save vision in as many people as possible, independent of the genetic cause of disease.
-
Nov 29, 2012
Research has suggested that DHA in your diet is good for preventing and treating cardiovascular diseases, neurological conditions, depression and a slew of other conditions and maladies, including those that affect the retina.
-
Oct 3, 2022
Atsena’s LCA-GUCY2D Gene Therapy Improves Vision in Phase 1/2 Clinical Trial
The company is planning to move the emerging treatment into a pivotal trial